Cargando…

Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study

BACKGROUND: Genetic studies have shown lipoprotein(a) (Lp[a]) to be an important causal risk factor for coronary disease. Apolipoprotein(a) isoform size is the chief determinant of Lp(a) levels, but its impact on the benefits of therapies that lower Lp(a) remains unclear. METHODS: HPS2-THRIVE (Heart...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parish, Sarah, Hopewell, Jemma C., Hill, Michael R., Marcovina, Santica, Valdes-Marquez, Elsa, Haynes, Richard, Offer, Alison, Pedersen, Terje R., Baigent, Colin, Collins, Rory, Landray, Martin, Armitage, Jane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841847/ https://www.ncbi.nlm.nih.gov/pubmed/29449329 http://dx.doi.org/10.1161/CIRCGEN.117.001696

Ejemplares similares

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
por: Haynes, Richard, et al.
Publicado: (2013)

How was it for you? - obtaining feedback from staff at study sites for the HPS2-thrive trial
por: Bray, Christopher, et al.
Publicado: (2015)

A key risk indicator approach to central statistical monitoring in multicentre clinical trials: method development in the context of an ongoing large-scale randomized trial
por: Elsa, Valdés-Márquez, et al.
Publicado: (2011)

Central statistical monitoring in multicentre clinical trials: developing statistical approaches for analysing key risk indicators
por: Valdes-Marquez, Elsa, et al.
Publicado: (2013)

Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom
por: Hopewell, Jemma C, et al.
Publicado: (2020)

Improving efficiency of on-site monitoring in multicentre clinical trials by targeting visits
por: Knott, Carol, et al.
Publicado: (2015)

The role of lipoprotein (a) in chronic kidney disease
por: Hopewell, Jemma C., et al.
Publicado: (2018)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
por: Chan, Dick C., et al.
Publicado: (2019)

Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials
por: Offer, Alison, et al.
Publicado: (2019)

Development and validation of an isoform-independent monoclonal antibody–based ELISA for measurement of lipoprotein(a)
por: Marcovina, Santica M., et al.
Publicado: (2022)

Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a)
por: Clark, Justin R., et al.
Publicado: (2022)

Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
por: Hopewell, Jemma C., et al.
Publicado: (2013)

HPS2-THRIVE, AIM-HIGH and dal-OUTCOMES: HDL-cholesterol under attack
por: Hassan, Mohamed
Publicado: (2014)

Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
por: Saleheen, Danish, et al.
Publicado: (2017)

Relative effects of LDL-C on ischemic stroke and coronary disease: A Mendelian randomization study
por: Valdes-Marquez, Elsa, et al.
Publicado: (2019)

Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke
por: Hopewell, Jemma C, et al.
Publicado: (2018)

International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B
por: Marcovina, Santica, et al.
Publicado: (1990)

Can vascular mortality be reliably ascertained from the underlying cause of death recorded on a medical death certificate? Evidence from 2800 adjudicated heart protection study (HPS) deaths
por: Herrington, William, et al.
Publicado: (2015)

Hermansky-Pudlak Syndrome: Identification of Novel Variants in the Genes HPS3, HPS5, and DTNBP1 (HPS-7)
por: Boeckelmann, Doris, et al.
Publicado: (2022)

The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
por: Parish, Sarah, et al.
Publicado: (2009)

Neprilysin inhibition in chronic kidney disease
por: Judge, Parminder, et al.
Publicado: (2015)

Mendelian randomization with fine‐mapped genetic data: Choosing from large numbers of correlated instrumental variables
por: Burgess, Stephen, et al.
Publicado: (2017)

Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9
por: Romagnuolo, Rocco, et al.
Publicado: (2017)

Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort
por: Matveyenko, Anastasiya, et al.
Publicado: (2023)

Report of Hermansky–Pudlak Syndrome in Two Families with Novel Variants in HPS3 and HPS4 Genes
por: Zaman, Qaiser, et al.
Publicado: (2023)

A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms
por: Mack, Salome, et al.
Publicado: (2017)

Evidence for the Prevention and Treatment of Stroke in Dialysis Patients
por: Herrington, William, et al.
Publicado: (2015)

Gene amplification of the Hps locus in Glycine max
por: Gijzen, Mark, et al.
Publicado: (2006)

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
por: Parish, Sarah, et al.
Publicado: (2022)

Lipoprotein Lipase (LPL) is Associated with Neurite Pathology and Its Levels Are Markedly Reduced in the Dentate Gyrus of Alzheimer’s Disease Brains
por: Gong, Huilin, et al.
Publicado: (2013)

Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic Epidemiology
por: Staplin, Natalie, et al.
Publicado: (2022)

A Novel Splice Site Mutation in HPS1 Gene is Associated with Hermansky-Pudlak Syndrome-1 (HPS1) in an Iranian Family
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2016)

Is HPS a valuable component of a STEM education? An empirical study of student interest in HPS courses within an undergraduate science curriculum
por: Lusk, Greg
Publicado: (2022)

Association between high molecular weight apolipoprotein isoforms and lipoprotein levels in advanced chronic kidney disease and the effect of hemodialysis
por: Gambhir, J. K., et al.
Publicado: (2013)

The Role of the Endothelium in HPS Pathogenesis and Potential Therapeutic Approaches
por: Gavrilovskaya, Irina, et al.
Publicado: (2012)

Connection between HPS and ACLF: a solution of chaos?
por: Maruyama, Hitoshi, et al.
Publicado: (2021)

Methodological Diversity in HPS-Informed Science Education Research
por: Erduran, Sibel
Publicado: (2021)

Plasma cytokines and risk of coronary heart disease in the PROCARDIS study
por: Clarke, Robert, et al.
Publicado: (2018)

Independent effects of adiposity measures on risk of atrial fibrillation in men and women: a study of 0.5 million individuals
por: Camm, C Fielder, et al.
Publicado: (2021)

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease
por: Schlackow, Iryna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_frdobko47qidbfa698pumbmhdm